tirzepatide weight loss trial Shows Superior Over Semaglutide in Phase 3 Lilly Decides to Advance Tirzepatide
Description
Tips for managing injection site reactions Similar to other diabetes and weight-loss medications that use injections, site reactions tend to occur more commonly if you're doing the injections at the same place on your body each time, says Sowa
Patients should understand that mild-to-moderate nausea is common and typically improves, but severe persistent vomiting, signs of dehydration, or new respiratory symptoms warrant medical evaluation
Published data from the SURPASS and SURMOUNT clinical trial programs has generated significant interest in dual incretin signaling
It plans on submitting the SUMMIT study data to the FDA and other regulatory agencies later in 2024
If there are fewer than 2 days, skip the missed dose and take your next dose on the scheduled day
The sad truth is that, in the US, 80% of people with sleep apnea remain untreated for the disease
